Data / Form D filings / Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc.: Form D filings
Petros Pharmaceuticals, Inc., a pharmaceuticals company in New York, NY, filed 4 Form D notices with the SEC between 2021 and 2023. The latest, on July 21, 2023, reports $30 million sold of a $30 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, New York, NY, 10036
- Phone
- (973) 242-0005
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1815903
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2023 | New notice | $30,000,006 | $30,000,006 | 15 | Jul 13, 2023 | sec.gov | |
| Jan 3, 2022 | New notice | $8,324,820 | $2,200,023 | $6,124,797 | 12 | Dec 22, 2021 | sec.gov |
| Dec 3, 2021 | New notice | $12,815,000 | $3,540,000 | $9,275,000 | 12 | Nov 29, 2021 | sec.gov |
| Oct 26, 2021 | New notice | $5,922,951 | $0 | $5,922,951 | 10 | Oct 13, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John D. Shulman | Director | |
| Mitchell Arnold | Executive Officer | |
| Wayne R. Walker | Director | |
| Fady Boctor | Executive Officer | |
| Gregory T. Bradley | Director | |
| Joshua N. Silverman | Director | |
| Bruce T. Bernstein | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jul 17, 2023 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Petros Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.